Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169) |
---|
01/05/2005 | EP1492790A1 Imidazo fused compounds |
01/05/2005 | EP1492789A1 Tropane derivatives as ccr5 modulators |
01/05/2005 | EP1492787A2 (condensed) pyrimidone and (condensed) pyridone compounds, processes for their preparation, and pharmaceutical compositions containing them |
01/05/2005 | EP1492784A2 Substituted 2,3-diphenyl pyridines |
01/05/2005 | EP1492781A1 N,n'-disubstituted piperazine compounds and the use of the same as analgesics |
01/05/2005 | EP1492780A1 5-substituted 1,1-dioxo-[1,2,5]thiazolidine-3-one derivatives as ptpase 1b inhibitors |
01/05/2005 | EP1492778A1 (4,2-disubstituted-thiazol-5-yl)amine compounds as pde7 inhibitors |
01/05/2005 | EP1492775A2 Oxo-azabicyclic compounds |
01/05/2005 | EP1492774A2 Pyrimidone derivatives useful for the treatment of inflammation and immunological diseases |
01/05/2005 | EP1492773A2 4-(heterocyclyl)-benzenesulfoximine compounds for the treatment of inflammation |
01/05/2005 | EP1492771A1 Quinoline and isoquinoline derivatives, method for the production thereof and use thereof as anti-inflammatory agents |
01/05/2005 | EP1492761A2 Amino acids with affinity for the alpha-2-delta-protein |
01/05/2005 | EP1492757A1 (2-((2-alkoxy)-phenyl)-cyclopent-1-enyl) aromatic carbo- and heterocyclic carboxylic acid and derivatives |
01/05/2005 | EP1492559A2 Truncated 24 kda basic fibroblast growth factor |
01/05/2005 | EP1492555A2 Compositions and methods for modulation of effects on phagocyte and lymphoid cell population |
01/05/2005 | EP1492554A2 Spherical protein particles and methods of making and using them |
01/05/2005 | EP1492552A2 Diagnostics and therapeutics for diseases associated with n-formyl peptide receptor like 1 (fprl1) |
01/05/2005 | EP1492550A1 Willow extract |
01/05/2005 | EP1492544A1 Pharmaceutical compositions containing water-soluble prodrugs of propofol and methods of administering same |
01/05/2005 | EP1492542A1 Hormone replacement therapy |
01/05/2005 | EP1492538A1 Meloxicam suppositories containing e.g. polyethylenglycol |
01/05/2005 | EP1492537A1 Morpholine derivatives with a substituted acetamide group in the 2-position for use as ccr-3 antagonists for the treatment of inflammatory diseases |
01/05/2005 | EP1492533A1 N-substituted pyridinone and pyrimidinone derivatives for use as lp-pla2 inhibitors in the treatment of artherosclerosis |
01/05/2005 | EP1492532A1 Combinations of epinastine, belladonna and pseudoephedrine as new pharmaceutical formulations |
01/05/2005 | EP1492530A1 Thiazol-2-yl-imine compounds as pde-7 inhibitors |
01/05/2005 | EP1492522A1 Ansamycin formulations and methods for producing and using same |
01/05/2005 | EP1492516A2 Use of mob-5 in pain |
01/05/2005 | EP1492512A1 Method for systemic drug delivery through the nail |
01/05/2005 | EP1492415A2 Method of improving absorption of vitamin e by a pet animal |
01/05/2005 | EP1492414A2 Method and dietary composition for improving fat digestibility |
01/05/2005 | EP1492413A2 Method and dietary composition for improving lipid digestibility |
01/05/2005 | EP1248630B9 Use of a dermatological composition containing oligosaccharides for the treatment of skin diseases |
01/05/2005 | EP1244440B1 Agonists specific for the peripheral cannabinoid receptor |
01/05/2005 | EP1226126B1 Pyrimidine derivatives |
01/05/2005 | EP1178801B1 Combination of nicotinic acid or nicotinamide with riboflavin for the treatment of pruritus, itching and inflammation disorders |
01/05/2005 | EP0682517B1 Photodynamic treatment of synovium |
01/05/2005 | DE19957065B4 Screening-Verfahren für Arzneistoffe A screening method for drugs |
01/05/2005 | DE10327428A1 Preparation of pyrrolidine-1,2-dicarboxanilide derivatives for use as factor Xa inhibiting antithrombotic agents, comprises reacting pyrrolidine-2-carboxylic acid with phenyl isocyanate then aniline derivative |
01/05/2005 | DE10297329T5 Dexibuprofen enthaltende Weichgelatinekapseln und Verfahren zu ihrer Herstellung Dexibuprofen-containing soft gelatin capsules and methods for their preparation |
01/05/2005 | CN1561393A Inhibitors of glycogen synthase kinase-3 (GSK-3) for treating glaucoma |
01/05/2005 | CN1561387A Probiotic bifidobacterium strains |
01/05/2005 | CN1561344A Angiogenesis-inhibitory tripeptides, compositions and their methods of use |
01/05/2005 | CN1561339A Process for preparing pyridyl-alkylsulfonyl pyrazole derivatives |
01/05/2005 | CN1561334A Indole derivatives as COXII inhibitors |
01/05/2005 | CN1561331A Diaryl sulfide derivative, addition salt thereof, and immunosuppressant |
01/05/2005 | CN1561246A Compositions of cyclooxygenase-2 selective inhibitors and radiation for inhibition or prevention of cardiovascular disease |
01/05/2005 | CN1561223A New drug |
01/05/2005 | CN1561222A Matrix metalloprotease inhibitor |
01/05/2005 | CN1561220A Method for the treatment of inflammation |
01/05/2005 | CN1561216A Novel compounds |
01/05/2005 | CN1561215A Salts of substituted 1, 2, 3, 4-tetrahydroquinoline-2-carboxylic acid compounds used as nmda antagonist |
01/05/2005 | CN1561211A Nociceptin analogs |
01/05/2005 | CN1561207A Therapeutic delivery of carbon monoxide |
01/05/2005 | CN1561204A Use of COX-2 inhibitors for preventing immunodeficiency |
01/05/2005 | CN1561203A Pharmaceutical salts |
01/05/2005 | CN1561201A Pharmaceutical compositions comprising colloidal silicon dioxide |
01/05/2005 | CN1561199A Pharmaceutical composition comprising lipids comprising a polar and a nonpolar moiety |
01/05/2005 | CN1560051A 取代吡唑化合物 A substituted pyrazole compound |
01/05/2005 | CN1560041A Compounds and methods for treatment of asthma, allergy and inflammatory disorders |
01/05/2005 | CN1559574A External used Chinese medicine for pain stopping |
01/05/2005 | CN1559566A Fengtongning Chinese medicinal preparaton and its preparation method |
01/05/2005 | CN1559557A External-used powder for treating rheumatism and hyperosteogeny |
01/05/2005 | CN1559555A Adhesive plaster for treating pain of shoulder |
01/05/2005 | CN1559554A Wind dispelling cold eliminating medicinal wine and its preparation method |
01/05/2005 | CN1559550A New type medicina preparation with one chinese medicinal herb extract ant its preparation method |
01/05/2005 | CN1559546A Insensitive impediment capsule and its manufacturing method |
01/05/2005 | CN1559542A Immune balancing energy restoring ointment and its manufacturing method |
01/05/2005 | CN1559533A Toxicity expelling wind damping joint curing wine |
01/05/2005 | CN1559519A Prunella spike extract and its preparation method and use |
01/05/2005 | CN1559507A Fumigant |
01/05/2005 | CN1559505A Wind dispelling dampness transforming blood circulating liquid |
01/05/2005 | CN1559496A Chinese medicine preparation of removing obstruction in the channels for treating atrophic arthritis |
01/05/2005 | CN1559487A Health-care spray for treating acute injury, chronic strain, rheumatalgia |
01/05/2005 | CN1559466A Traditional Chinese medicinal plaster |
01/05/2005 | CN1559456A Traditional Chinese medicinal prepn.-defervescent capsule for treating presistent febris during common cold, and prepn. method therefor |
01/05/2005 | CN1559452A Navel applicaton powder medicine made of many kinds of herb medicines for treating rheumatoid diseases, and application method thereof |
01/05/2005 | CN1559451A Medicine compound having synergistic action |
01/05/2005 | CN1559413A Freezing-drying powder-injection contg. dexamethasone sodium phosphate, and its prepn. method |
01/05/2005 | CN1559401A Therapeutic use and compositions involving isoflavones |
01/05/2005 | CN1559393A Freezing-drying sterile prepn. used for injection contg. sodium naproxen |
01/05/2005 | CN1559390A Oral disintegration tablets contg. p-acetaminophenol, and prepn. method therefor |
01/05/2005 | CN1559386A Method for preparing emodin liquid |
01/05/2005 | CN1183156C Heterocyclic compounds, intermediates thereof and elastase inhibitors |
01/05/2005 | CN1183149C Pharmaceutical compositions containing oligosaccharides and preparation thereof |
01/05/2005 | CN1183148C Selective crystallization of 3-pyridyl-1-hydroxyethylidene-1,1-bisphosphonic acid sodium 2.5 hydrate or monohydrate |
01/05/2005 | CN1183136C Indoloquinazolinones |
01/05/2005 | CN1183126C Dihydrobenzofuran and related compounds useful as anti-inflammatory agents |
01/05/2005 | CN1183122C Dipeptide nitrile cathepsin K inhibitors |
01/05/2005 | CN1183119C Arylpiperzines as metalloproteinase inhibiting agents (MMP) and their use |
01/05/2005 | CN1183107C Alkynyl containing hydroxamic acid compounds as TACE inhibitors |
01/05/2005 | CN1183098C 3-amino-3-aryl-1-alcohol derivatives and preparation and use thereof |
01/05/2005 | CN1182869C Vascular irrigation solution and method for inhibition of pain, inflammation, spasm and restemosis |
01/05/2005 | CN1182866C Medicinal liquor for curing rheumatism and traumatic injuries |
01/04/2005 | US6839604 Compliance tracking method |
01/04/2005 | US6838584 Estrogen receptor modulators |
01/04/2005 | US6838574 Induction cell differentiation; leukemia therapy |
01/04/2005 | US6838559 Such as 2-((6-(((4-(3,4-dimethoxyphenyl)methyl)amino)-7-ethyl-7H-purin-2-yl)amino) -4,5-methyl-N-phenyl-5-thiazole-carboxamide for treatment of lymphocyte mediated diseases such as transplant rejection and graft versus host disease |
01/04/2005 | US6838476 Imidazoles with anti-inflammatory activity |
01/04/2005 | US6838471 Inhibition of inflammatory cytokine production by cholinergic agonists and vagus nerve stimulation |
01/04/2005 | US6838466 Compounds for the treatment of inflammatory disorders |